Clinical Trials Directory

Trials / Completed

CompletedNCT04184388

Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Cognitive Function

A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Cognitive Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Chonbuk National University Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

This study was the evaluate the efficacy and safety of hydrolysed red ginseng extract on the improvement of Cognitive Function

Detailed description

This study was 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate. 100 subjects participated in hydrolysed red ginseng extract or placebo group. To evaluate the changes in the evaluation items when hydrolysed red ginseng extract was taken 12 weeks compared with placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHydrolysed Red Ginseng Extractonce a day for 1 p.o., after breakfast(10 ml/day, Hydrolysed Red Ginseng extract for 1g/day) for 12 week
DIETARY_SUPPLEMENTPlaceboonce a day for 1 p.o., after breakfast(10 ml/day, Hydrolysed Red Ginseng extract for 0g/day) for 12 week

Timeline

Start date
2019-11-01
Primary completion
2020-09-28
Completion
2020-11-30
First posted
2019-12-03
Last updated
2021-01-27

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04184388. Inclusion in this directory is not an endorsement.